1. European Urology Focus
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50–69 yr Compared with Current Prostate Cancer Testing 
Martin Eklund, Tobias Nordström, Markus Aly, Jan Adolfsson, Peter Wiklund, Yvonne Brandberg, James Thompson, Fredrik Wiklund, Johan Lindberg, Joseph C. Presti, Mark StLezin, Mark Clements, Lars Egevad, Henrik Grönberg 
European Urology Focus 
DOI: /j.euf
Copyright © Terms and Conditions

2. Fig. 1
Comparison of Gleason Score ≥7 detection rate and biopsy results in different prostate-specific antigen (PSA) ranges for Current Prostate Cancer Testing (CPT) and Stockholm-3 Model (S3M), respectively.
CI=confidence interval; GS=Gleason Score.
European Urology Focus DOI: ( /j.euf )
Copyright © Terms and Conditions